Dietary supplements for lipedema.

Dietary supplements Fat burners Fat burning supplements Weight loss in lipedema

Journal

Journal of preventive medicine and hygiene
ISSN: 2421-4248
Titre abrégé: J Prev Med Hyg
Pays: Italy
ID NLM: 9214440

Informations de publication

Date de publication:
Jun 2022
Historique:
entrez: 8 12 2022
pubmed: 9 12 2022
medline: 15 12 2022
Statut: epublish

Résumé

Lipedema is a chronic disease that mostly manifests in females as the abnormal distribution of subcutaneous adipose connective tissue, usually coupled with bruising, pain, and edema. Lipedema molecular pathophysiology is currently not clear, but several studies suggest that genetics and hormonal imbalance participate in lipedema pathogenesis. Women with lipedema present in some cases with elevated body mass index, and the appearance of obesity in addition to lipedema, where the obesity can cause serious health issues as in lipedema-free individuals with obesity, such as diabetes and cardiovascular disorders. Unlike obesity, lipedema tissue does not respond well to diet or physical exercise alone. Therefore, in this review we discuss the effect of various dietary supplements that, along with diet and physical exercise, cause fat burning and weight loss, and which could potentially be important in the treatment of lipedema. Indeed, an effective fat burner should convert stored fats into energy, mobilize and break down triglycerides in adipocytes, boost metabolism and inhibit lipogenesis. Common ingredients of fat burning supplements are green tea, caffeine, chromium, carnitine, and conjugated linoleic acid. The use of fat burners could act synergistically with a healthy diet and physical exercise for decreasing adipose tissue deposition in patients with lipedema and resolve related health issues. The effects of fat burners in human studies are sometimes contradictory, and further studies should test their effectiveness in treating lipedema.

Identifiants

pubmed: 36479502
doi: 10.15167/2421-4248/jpmh2022.63.2S3.2758
pmc: PMC9710418
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

E169-E173

Informations de copyright

©2022 Pacini Editore SRL, Pisa, Italy.

Références

Obes Rev. 2016 Oct;17(10):970-6
pubmed: 27335245
Eur Rev Med Pharmacol Sci. 2019 Feb;23(4):1751-1761
pubmed: 30840300
J Steroid Biochem Mol Biol. 2002 Dec;83(1-5):245-51
pubmed: 12650722
J Nutr. 2009 Feb;139(2):264-70
pubmed: 19074207
Obes Rev. 2013 Jun;14(6):496-507
pubmed: 23495911
EMBO Rep. 2001 Apr;2(4):282-6
pubmed: 11306547
J Nutr Biochem. 2003 May;14(5):251-8
pubmed: 12832028
J Nutr Biochem. 2007 Sep;18(9):629-34
pubmed: 17418559
Regul Toxicol Pharmacol. 2015 Oct;73(1):196-200
pubmed: 26160596
PLoS One. 2015 Apr 15;10(4):e0123854
pubmed: 25875200
Food Addit Contam. 2003 Jan;20(1):1-30
pubmed: 12519715
J Pers Med. 2022 Feb 11;12(2):
pubmed: 35207755
Nutrients. 2021 Jan 25;13(2):
pubmed: 33504026
Diabetes Technol Ther. 2008 Oct;10(5):405-12
pubmed: 18715218
Am J Clin Nutr. 2004 Apr;79(4):529-36
pubmed: 15051593
Int J Mol Sci. 2020 Aug 29;21(17):
pubmed: 32872468
JAMA. 2003 Mar 26;289(12):1537-45
pubmed: 12672771
Cochrane Database Syst Rev. 2013 Nov 29;(11):CD010063
pubmed: 24293292
Am J Clin Nutr. 2014 May;99(5):984-91
pubmed: 24622806
Mini Rev Med Chem. 2004 Oct;4(8):847-57
pubmed: 15544546
Int J Sport Nutr Exerc Metab. 2012 Apr;22(2):139-54
pubmed: 22465867
Horm Mol Biol Clin Investig. 2018 Mar 9;33(1):
pubmed: 29522416
Alcohol. 2011 Jun;45(4):349-54
pubmed: 21051179
Am J Clin Nutr. 1992 Jan;55(1 Suppl):219S-227S
pubmed: 1345885
Pol Merkur Lekarski. 2002 Aug;13(74):129-32
pubmed: 12420344
Maturitas. 2012 Dec;73(4):280-7
pubmed: 22986087
Pharmaceuticals (Basel). 2021 Nov 22;14(11):
pubmed: 34832979
Eur Rev Med Pharmacol Sci. 2019 Jul;23(13):5581-5594
pubmed: 31298310
Meat Sci. 2008 Apr;78(4):343-58
pubmed: 22062452
Phytother Res. 2017 Oct;31(10):1463-1474
pubmed: 28752649
Am J Clin Nutr. 1989 Jan;49(1):44-50
pubmed: 2912010
Lymphat Res Biol. 2021 Aug;19(4):322-333
pubmed: 33373545
Nutrients. 2019 Jul 17;11(7):
pubmed: 31319633
Am J Clin Nutr. 2004 Jan;79(1):40-6
pubmed: 14684395
Life (Basel). 2021 Dec 15;11(12):
pubmed: 34947933
Arzneimittelforschung. 2002;52(1):1-7
pubmed: 11838268
Eur Rev Med Pharmacol Sci. 2021 Dec;25(1 Suppl):14-22
pubmed: 34890030
Obes Rev. 2011 Oct;12(10):841-51
pubmed: 21951331
Int J Mol Sci. 2022 Jul 03;23(13):
pubmed: 35806420
Drug Test Anal. 2016 Mar-Apr;8(3-4):357-69
pubmed: 26391406
Eur Rev Med Pharmacol Sci. 2021 Dec;25(1 Suppl):33-42
pubmed: 34890032
J Med Food. 2006 Fall;9(3):400-7
pubmed: 17004906
Obesity (Silver Spring). 2019 Oct;27(10):1567-1576
pubmed: 31544340
Proc Natl Acad Sci U S A. 2000 Nov 7;97(23):12735-40
pubmed: 11070087
Eur J Appl Physiol. 2017 Sep;117(9):1907-1915
pubmed: 28702809
Obes Rev. 2015 Jul;16(7):581-606
pubmed: 25982085
Front Nutr. 2018 Sep 04;5:77
pubmed: 30234122
Dermatol Ther. 2021 Jan;34(1):e14364
pubmed: 33001552
Crit Rev Food Sci Nutr. 2014;54(1):17-23
pubmed: 24188231
Dtsch Arztebl Int. 2020 Jun 1;117(22-23):396-403
pubmed: 32762835
J Nutr. 2002 Oct;132(10):3228S-33S
pubmed: 12368423
N Engl J Med. 1996 Aug 29;335(9):609-16
pubmed: 8692238
Eur J Clin Nutr. 2003 Oct;57(10):1268-74
pubmed: 14506488

Auteurs

Gabriele Bonetti (G)

MAGI'S LAB, Rovereto (TN), Italy.

Karen L Herbst (KL)

Total Lipedema Care, Beverly Hills California and Tucson Arizona, USA.

Kristjana Dhuli (K)

MAGI'S LAB, Rovereto (TN), Italy.

Aysha Karim Kiani (AK)

MAGI EUREGIO, Bolzano, Italy.

Serena Michelini (S)

Unit of Physical Medicine, Sapienza University of Rome, Rome, Italy.

Silvia Michelini (S)

Neurosurgery, University of Tor Vergata, Rome, Italy.

Maria Rachele Ceccarini (MR)

Department of Pharmaceutical Sciences; University of Perugia, Perugia.

Sandro Michelini (S)

Vascular Diagnostics and Rehabilitation Service, Marino Hospital, ASL Roma 6, Marino, Italy.

Maurizio Ricci (M)

Division of Rehabilitation Medicine, Azienda Ospedaliero-Universitaria, Ospedali Riuniti di Ancona, Italy.

Marina Cestari (M)

Study Centre Pianeta Linfedema, Terni, Italy.
Lymphology Sector of the Rehabilitation Service, USL Umbria 2, Terni, Italy.

Michela Codini (M)

Department of Pharmaceutical Sciences; University of Perugia, Perugia.

Tommaso Beccari (T)

Department of Pharmaceutical Sciences; University of Perugia, Perugia.

Francesco Bellinato (F)

Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.

Paolo Gisondi (P)

Section of Dermatology and Venereology, Department of Medicine, University of Verona, Verona, Italy.

Matteo Bertelli (M)

MAGI'S LAB, Rovereto (TN), Italy.
MAGI EUREGIO, Bolzano, Italy.
MAGISNAT, Peachtree Corners (GA), USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH